Last 820.20 INR
Change Today -31.45 / -3.69%
Volume 15.0K
ASTR On Other Exchanges
Natl India
As of 7:05 AM 10/20/14 All times are local (Market data is delayed by at least 15 minutes).

astrazeneca pharma india ltd (ASTR) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/4/14 - 1,286
52 Week Low
01/30/14 - 725.20
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

astrazeneca pharma india ltd (ASTR) Related Businessweek News

No Related Businessweek News Found

astrazeneca pharma india ltd (ASTR) Details

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. The company primarily offers products in the areas of cardiovascular and metabolic diseases; oncology; respiratory, inflammation, and autoimmunity; and infection, neuroscience, and gastrointestinal diseases. It also provides clinical trial services on pharmaceutical products. The company was founded in 1979 and is headquartered in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.

1,559 Employees
Last Reported Date: 09/11/14
Founded in 1979

astrazeneca pharma india ltd (ASTR) Top Compensated Officers

Managing Director, Director, Member of Share ...
Total Annual Compensation: 12.3M
Whole-Time Director and Member of Share Trans...
Total Annual Compensation: 8.7M
Compensation as of Fiscal Year 2014.

astrazeneca pharma india ltd (ASTR) Key Developments

AstraZeneca Pharma India Limited Announces Change in Registered Office Address

AstraZeneca Pharma India Ltd. announced that effective September 01, 2014, the Registered Office of the company has been shifted from 'Avishkar', Off Bellary Road, Hebbal, Bangalore - 560 024 to Block N1, 12th Floor, Manyata Embassy Business Park, Rachenahalli, Outer Ring Road, Bangalore - 560 045.

AstraZeneca Pharma India Limited, Annual General Meeting, Sep 30, 2014

AstraZeneca Pharma India Limited, Annual General Meeting, Sep 30, 2014., at 15:00 Indian Standard Time. Location: Vivanta by Taj Hotel. Agenda: To consider audited balance sheet as at March 31, 2014 and the audited profit and loss account; to appoint director; to appoint Messrs. BSR & Co. LLP, Chartered Accountants, as statutory auditors; to consider ratification of cost auditor's remuneration; to appoint independent director; and to appoint independent director.

AstraZeneca Pharma India Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

AstraZeneca Pharma India Limited reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported total income from operations (net) of INR 1,256.428 million compared to INR 1,252.026 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 193.932 million compared to INR 11.052 million a year ago. Loss from ordinary activities before tax was INR 176.002 million compared to profit from ordinary activities before tax of INR 17.684 million a year ago. Net loss for the period was INR 176.002 million or INR 7.04 per basic and diluted share, compared to net profit INR 17.684 million or INR 0.71 per basic and diluted share, a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ASTR:IN 820.20 INR -31.45

ASTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ASTR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ASTR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 4.2x
Price/Book 11.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 4.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PHARMA INDIA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at